# OnCo record neovii (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/neovii/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "neovii" ;
  schema:name "Neovii"@en ;
  schema:alternateName "Neovii Biotech"@en, "Neovii Biotech GmbH"@en, "Neovii Pharmaceuticals AG"@en ;
  schema:description "Neovii is a Swiss company whose anti-T-lymphocyte globulin, Grafalon, is given before stem cell transplants to lower the risk of graft versus host disease."@en ;
  schema:url <https://onco.cc/companies/neovii/>, <https://www.neovii.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://www.neovii.com>, <https://clinicaltrials.gov/search?lead=Neovii> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "CH" ;
  onco:cancers <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/all-leukemia/> ;
  onco:technologies <https://onco.cc/technologies/allogeneic-hsct/> ;
  onco:terms <https://onco.cc/terms/allogeneic-transplant/> .